Thus, fibroblasts, stroma, blood vessels and other immune cells in the TME, are still sialylated and therefore, might compensate for the lack of ST3Gal5 from tumor cells (Fig. S3E). This evidence concerns the gene ST3GAL5 and neoplasm.